COVID-2019 Alert

The latest information about the 2019 Novel Coronavirus, including vaccine clinics for children ages 6 months and older.

La información más reciente sobre el nuevo Coronavirus de 2019, incluidas las clínicas de vacunación para niños de 6 meses en adelante.

  • Virtual visitsVirtual visits
  • """"
  • Hayden after surgeryHayden after surgery

Pulmonary Vascular Disease Program

Pulmonary vascular disease (PVD) occurs when blood vessels in the lungs do not form correctly when a baby is in the womb or when blood vessels become abnormally narrowed over time. PVD includes any condition that impacts the blood vessels in the lungs. Some types of pulmonary vascular disease cause pulmonary hypertension (PH), or high blood pressure in the lungs. Your child might have pulmonary vascular disease if he or she has a congenital heart diseaseheart failure, liver failure, or was born prematurely. Other children may have a genetic cause or develop it over time for reasons we do not yet understand.

As national leaders in the research, diagnosis, and treatment of pulmonary vascular disease, we established the Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford—a joint program between Stanford Medicine Children’s Health and our adult hospital, Stanford Health Care—to offer children innovative and exceptional care in a nurturing and child-friendly environment. Our specialized team of doctors, nurse practitioners, and social workers is with you every step of the way in your child’s care journey. We treat children of all ages with all different types of pulmonary vascular disease.

Why choose Stanford Medicine Children’s Health for pulmonary vascular disease care

When it comes to caring for your child, we tap into years of experience, renowned experts, groundbreaking research, and highly specialized programs. All this translates into tailored, comprehensive care for your child.

  • Proven national leaders in treating pulmonary vascular disease in children. Out of the 250+ children’s hospitals nationwide, only a small number have a dedicated pulmonary vascular disease program like ours. Established over 20 years ago, our program is not only one of the longest-standing programs in the nation, it is also one of the largest, caring for hundreds of children from across the country and the world.
  • Innovative, research-driven pulmonary vascular disease therapies. We offer all FDA-approved therapies for pulmonary vascular disease, plus a variety of groundbreaking, cutting-edge therapies supported by basic science and clinical researchers associated with the Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford. We welcome you to contact us to learn about our ongoing clinical trials.
  • Pulmonary vascular disease specialists working together for you and your child. You will find an expert team of internationally recognized individuals who focus on pulmonary vascular disease and work together toward the common goal of providing your child with the highest quality care available and the best chance at exceptional outcomes.
  • Collaboration with other specialty pediatric programs for personalized care. When pulmonary vascular disease is related to other health conditions, we work with subspecialty programs within Stanford Medicine Children’s Health to provide holistic, multidisciplinary care. We collaborate with the following highly specialized programs: